世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ヘルスケア／医療シミュレーション市場：製品・サービス別（患者シミュレーター、高忠実度シミュレーター、低忠実度シミュレーター、タスクトレーナー、手術シミュレーター、バーチャルチューターエンドユーザー別（学術機関、病院） - 2026年までの世界予測


Healthcare/Medical Simulation Market by Product and Service (Patient Simulators, High Fidelity Simulators, Low Fidelity Simulators, Task Trainer, Surgical Simulators, Virtual tutor) By End User (Academic Institutes, Hospital) - Global Forecast to 2026

ヘルスケア/医療シミュレーション市場は、2021年から2026年までの年平均成長率15.1%で、2021年の17億米ドルから2026年には34億米ドルに達すると予想されています。医療シミュレーション市場の成長を促している主... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2021年9月7日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		297 255 英語

※ 調査会社の事情により、予告なしに価格が変更になる場合がございます。
最新の価格はデータリソースまでご確認ください。
日本語のページは自動翻訳を利用し作成しています。


　

サマリー

ヘルスケア/医療シミュレーション市場は、2021年から2026年までの年平均成長率15.1%で、2021年の17億米ドルから2026年には34億米ドルに達すると予想されています。医療シミュレーション市場の成長を促している主な要因は、トレーニング中の生身の患者へのアクセスが限られていること、医学教育の進歩、低侵襲治療への需要の高まり、患者の安全性への関心の高まり、COVID-19パンデミックの影響によるバーチャルトレーニングの需要の高まりなどです。さらに、新興国におけるシミュレーション教育に関する意識の高まりや、医療従事者の不足などの要因が、市場関係者に有利な機会をもたらしています。
"予測期間中、腹腔鏡手術シミュレーターのセグメントが最大のシェアを占める"
2020年のインターベンション/手術用シミュレータ市場では、腹腔鏡手術用シミュレータが最大のシェアを占めています。腹腔鏡手術におけるシミュレーション技術の採用率の高さと技術革新が、予測期間中にこのセグメントの大きなシェアを占めています。
"学術機関セグメントは、2021年から2026年にかけて最も高いCAGRで成長する。"
医療シミュレーション市場は、エンドユーザーに基づき、学術機関、軍事組織、病院、その他に分類されます。2020年の医療シミュレーション市場では、学術機関セグメントが最大のシェアを占めており、次いで病院、軍事組織となっています。このセグメントが成長した要因としては、従来の学習からの段階的な移行、シミュレーションベースの高度な技術の登場、医療手術におけるシミュレーションモデルの幅広い活用、エラーの最小化への関心の高まり、医師の手順トレーニングの費用対効果などが挙げられます。
"予測期間中、APACが最も高い成長率を示す"
アジア太平洋地域の市場は、予測期間中に最も高いCAGRで成長すると予測されています。APAC地域の市場成長は、主に医学教育、トレーニング、および研究への注目度の高まりと、患者の安全性への注目度の高まり、および医療費の増加が要因となっています。
主要参加者の内訳
- 企業タイプ別 - Tier 1-35%、Tier 2-45%、Tier 3-20%。
- 役職別 - Cレベル-35%, ディレクターレベル-25%, その他-40
- 地域別 - 北米-45%、欧州-30%、アジア太平洋-20%、ラテンアメリカ-3%、中東・アフリカ-2

ヘルスケア／医療シミュレーション市場の主要プレイヤー
ヘルスケア／医療シミュレーション市場で活躍する主要プレイヤーは、CAE Inc.(カナダ）、Laerdal Medical（ノルウェー）、3D Systems（米国）、Gaumard Scientific Co.(米国)、Limb & Things (米国)、Surgical Science Sweden AG (スウェーデン)、京都化学 (日本)、Mentice AB (スウェーデン)、Intelligent Ultrasound Group Plc (英国)、Simulab Corp.(米国), Simulaids (米国).
リサーチカバレッジ
本レポートでは、様々な医療シミュレーション企業とその市場での採用パターンを分析しています。製品やサービス、エンドユーザー、地域などのセグメント別に、世界のヘルスケア/医療シミュレーション市場の市場規模と今後の成長性を推定することを目的としています。また、この市場の主要プレイヤーの会社概要、サービス内容、最近の開発状況、主要な市場戦略とともに、詳細な競合分析を行っています。
このレポートを購入する理由
本レポートは、既存の企業だけでなく、新規参入者や小規模な企業にとっても、市場の動向を把握するのに役立ち、より大きなシェアを獲得するのに役立つでしょう。本レポートを購入した企業は、市場での地位を強化するために、以下の戦略のいずれか、または組み合わせて使用することができます。
本レポートでは、以下の項目について分析しています。
市場への浸透。ヘルスケア／医療シミュレーション市場のトッププレイヤーが提供するサービスポートフォリオに関する包括的な情報
サービスの立ち上げ/イノベーション。ヘルスケア/医療シミュレーション市場における新サービスの立ち上げに関する詳細な洞察
市場開拓。製品・サービス別、エンドユーザー別、地域別の収益性の高い新興市場に関する包括的な情報
市場の多様化ヘルスケア/医療シミュレーション市場における新サービス、成長地域、最近の開発状況に関する詳細な情報
競合評価ヘルスケア/医療シミュレーション市場における主要企業の成長戦略、サービス、製造能力に関する詳細な評価を行います。

ページTOPに戻る


目次

1 はじめに 33
1.1 調査の目的 33
1.2 市場の定義と範囲 33
1.2.1 本調査の対象となるものとならないもの 33
1.2.2 市場のセグメンテーション 34
図1 医療シミュレーション市場のセグメンテーション 34
1.2.3 調査で考慮した年数 34
1.3 通貨 35
表1：米ドルへの換算に利用した為替レート 35
1.4 ステークホルダー 35
1.5 制限 36
1.6 変更点のまとめ 36
2 調査方法 37
2.1 調査方法 37
37 2.2 調査方法の設計 37
図2 医療シミュレーション市場：研究デザイン 37
2.2.1 二次調査 37
2.2.1.1 二次情報源からの主要データ 38
2.2.2 一次データ 39
2.2.2.1 一次資料 39
2.2.2.2 一次情報源からの主要データ 40
2.2.2.3 プライマリーエキスパートからの洞察 40
図3 一次インタビューの内訳。サプライサイドとデマンドサイドの 
需要サイドの参加者 41
図4 一次インタビューの内訳 企業別、呼称別、地域別 
企業別、用途別、地域別 41
2.3 市場規模の予測：医療シミュレーション市場 41
図5 供給側の市場規模予測：レベニューシェア分析 42
図6 公開企業上位3社の収益分析。外科用シーラント・接着剤分野（2020年） 42
図7 ボトムアップアプローチ-セグメント外挿法 43
図8 医療シミュレーション市場における推進要因、抑制要因、機会、および課題の分析による経済成長予測（2021-2026年） 44
図9 CAGRの予測 供給サイドの分析 44
2.4 市場の内訳とデータの三角測量 46
図10 三角測量の方法 46
2.5 市場シェアの推定 47
2.6 調査の前提条件 47
2.7 制限事項 48
2.7.1 方法論に関する制限 48
2.8 リスク評価 48
表2 リスク評価 医療シミュレーション市場 48
3 エグゼクティブサマリー 49
図11 医療シミュレーション市場、製品・サービス別。
2021年 vs. 2026年 （百万米ドル） 49
図12 インターベンショナル/サージェリーシミュレーター市場、タイプ別。
2021年 対 2026年 （単位：百万米ドル） 50
図13 医療用シミュレータ市場、エンドユーザー別。
2021年 対 2026年 (百万米ドル) 50
図14 医療用シミュレーション市場：地域別スナップショット 51
4 プレミアムインサイト 53
4.1 医療シミュレーション市場の概要 53
図15 医療技術の進歩が市場成長の主な要因 53 
市場成長の鍵となる要因 53
4.2 アジア太平洋地域：医療シミュレーション市場、製品・サービス別 
および国別（2019年） 54
図16 2020年のアジア太平洋地域の市場では、医療シミュレーションの解剖モデル分野と日本が最大のシェアを占めている 54
4.3 医療シミュレーション市場：地理的な成長機会 55
図17 予測期間中、中国が最高の成長を遂げる 55
4.4 地域別構成：医療シミュレーション市場 56
図18 予測期間中、北米が医療シミュレーション市場を支配する 
予測期間中、北米が医療シミュレーション市場を支配する 56
4.5 医療シミュレーション市場：発展途上国 vs. 先進国 56 先進国と途上国の比較 56
図19 予測期間中、発展途上国が高い成長を遂げる 
56
5 市場の概要 57
5.1 導入 57
5.2 市場力学 57
図20 医療シミュレーション市場：推進要因、抑制要因、機会、課題 57 
機会、および課題 57
5.2.1 ドライバー 58
5.2.1.1 医療トレーニング中の患者へのアクセスが制限される 58
5.2.1.2 医学教育における技術の進歩 58
5.2.1.3 低侵襲性治療に対する需要の高まり 59
5.2.1.4 患者の安全性への関心の高まり 59
59 5.2.1.5 COVID-19パンデミックの影響でバーチャルな交流を好む傾向が強まっている 
59 5.2.1.5 COVID-19パンデミックによるバーチャルインタラクションへの関心の高まり 59
 
5.2.2 阻害要因 60
5.2.2.1 限られた資金しか利用できない 60
5.2.2.2 医療用シミュレーターのデザインが悪い 60
5.2.3 機会 61
5.2.3.1 医療従事者の不足 61
5.2.3.2 新興国でのシミュレーショントレーニングに対する意識の高まり 61
5.2.4 市場の課題 62
5.2.4.1 シミュレーターのコスト高 62
5.2.4.2 オペレーション上の課題 62
5.3 ポーターズファイブフォース分析 63
表3 ポーターズ・ファイブフォース分析 63
5.3.1 新規参入者の脅威 63
5.3.2 競合他社の脅威 64
5.3.3 サプライヤーのバーゲニング・パワー 64
5.3.4 買い手のバーゲニング・パワー 64
64 5.3.5 競合他社との競争の激化 64
5.4 医療シミュレーション市場におけるCovid-19の影響 65
5.5 価格分析 65
表4 医療シミュレーションソリューションの価格帯 66
5.6 技術分析 66
5.7 エコシステム分析 67
5.7.1 医療シミュレーション市場: エコシステム分析 67
5.8 特許分析 67
5.8.1 医療シミュレーションに関する特許公開動向 67
図21 特許公開動向（2011年1月～2021年6月） 68
5.8.2 管轄地域と上位出願人の分析 68
図22 医療シミュレーション関連特許の上位出願人および所有者（企業/機関）（2011年1月～2021年6月） 69
図23 医療シミュレーション特許の上位出願国/地域 (2011年1月～2021年6月) 69
6 業界の洞察 70
6.1 はじめに 70
6.2 業界のトレンド 70
6.2.1 医療シミュレーションにおけるバーチャルリアリティ(VR)とオーグメンテッドリアリティ(AR)の利用 
70 6.2.1 医療シミュレーションにおけるバーチャルリアリティ（VR）および拡張現実（AR）の利用
6.2.2 ハイフィデリティ技術の進歩 71
6.2.3 シミュレータの開発におけるマルチモーダルなアプローチ 71
6.2.4 外科手術におけるAIおよびMLソフトウェアの利用 71
6.2.5 HCT/EMRの利用拡大 72

　

ページTOPに戻る


　

Summary

The healthcare/medical simulation market is expected to reach USD 3.4 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 15.1% from 2021 to 2026. The limited access to live patients during training, advancements in medical education, increasing demand for minimally invasive treatments, increasing focus on patient safety, and growing demand for virtual training due to current COVID-19 pandemic are the major factors driving the growth of the medical simulation market. Moreover, factors such as growing awareness pertaining to simulation education in emerging countries and shortage of healthcare personnel are creating lucrative opportunities for the market players.
“Laparoscopic surgical simulators segment to have the largest share during the forecast period.”
Laparoscopic surgical simulators accounted for the largest share of the interventional/surgical simulators market in 2020. The high adoption of simulation techniques in laparoscopy and technological innovations are responsible for the large share of this segment during the forecast period.
“Academic institutes segment to grow at the highest CAGR from 2021 to 2026.”
Based on end user, the medical simulation market is segmented into academic institutes, military organizations, hospitals and others. In 2020, the academic institute segment accounted for the largest share of the medical simulation market in 2020, followed by hospitals and military organizations. Factors responsible for the growth of this segment are the gradual shift of focus away from traditional learning, advent of advanced simulation-based technologies, wide utilization of simulation models in medical surgeries, increasing focus on minimizing errors, and cost-effectiveness of procedural training for medical physicians.
“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by the increasing focus on medical education, training, & research and the increasing focus on patient safety and increasing healthcare expenditure.
Break of primary participants:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the healthcare/medical simulation market
The key players operating in the healthcare/medical simulation market include CAE Inc. (Canada), Laerdal Medical (Norway), 3D Systems (US), Gaumard Scientific Co. (US), Limbs & Things (US), Surgical Science Sweden AG (Sweden), Kyoto Kagaku (Japan), Mentice AB (Sweden), Intelligent Ultrasound Group Plc (UK), Simulab Corp. (US), Simulaids (US).
Research Coverage:
The report analyzes the various medical simulation companies and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global healthcare/medical simulation market for different segments such as product and service, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.
The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the service portfolios offered by the top players in the healthcare/medical simulation market
 Service Launch/Innovation: Detailed insights on new service launches in the healthcare/medical simulation market
 Market Development: Comprehensive information about lucrative emerging markets, by product and service, end user, and region
 Market Diversification: Exhaustive information about new services, growing geographies, recent developments in the healthcare/medical simulation market
 Competitive Assessment: In-depth assessment of growth strategies, services, and manufacturing capabilities of leading players in the healthcare/medical simulation market.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION & SCOPE 33
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 33
1.2.2 MARKET SEGMENTATION 34
FIGURE 1 MEDICAL SIMULATION MARKET SEGMENTATION 34
1.2.3 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 35
1.4 STAKEHOLDERS 35
1.5 LIMITATIONS 36
1.6 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH APPROACH 37
2.2 RESEARCH METHODOLOGY DESIGN 37
FIGURE 2 MEDICAL SIMULATION MARKET: RESEARCH DESIGN 37
2.2.1 SECONDARY RESEARCH 37
2.2.1.1 Key data from secondary sources 38
2.2.2 PRIMARY DATA 39
2.2.2.1 Primary sources 39
2.2.2.2 Key data from primary sources 40
2.2.2.3 Insights from primary experts 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND 
DEMAND-SIDE PARTICIPANTS 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, 
DESIGNATION, AND REGION 41
2.3 MARKET SIZE ESTIMATION: MEDICAL SIMULATION MARKET 41
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 6 REVENUE ANALYSIS OF THE TOP 3 PUBLIC COMPANIES: SURGICAL SEALANTS AND ADHESIVES SEGMENT (2020) 42
FIGURE 7 BOTTOM-UP APPROACH—SEGMENTAL EXTRAPOLATION 43
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE MEDICAL SIMULATION MARKET (2021-2026) 44
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 46
FIGURE 10 DATA TRIANGULATION METHODOLOGY 46
2.5 MARKET SHARE ESTIMATION 47
2.6 ASSUMPTIONS FOR THE STUDY 47
2.7 LIMITATIONS 48
2.7.1 METHODOLOGY-RELATED LIMITATIONS 48
2.8 RISK ASSESSMENT 48
TABLE 2 RISK ASSESSMENT: MEDICAL SIMULATION MARKET 48
3 EXECUTIVE SUMMARY 49
FIGURE 11 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2021 VS. 2026 (USD MILLION) 49
FIGURE 12 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2021 VS. 2026 (USD MILLION) 50
FIGURE 13 MEDICAL SIMULATOR MARKET, BY END USER, 
2021 VS. 2026 (USD MILLION) 50
FIGURE 14 MEDICAL SIMULATION MARKET: REGIONAL SNAPSHOT 51
4 PREMIUM INSIGHTS 53
4.1 MEDICAL SIMULATION MARKET OVERVIEW 53
FIGURE 15 ADVANCEMENTS IN MEDICAL TECHNOLOGY IS A KEY FACTOR 
DRIVING THE MARKET GROWTH 53
4.2 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE 
AND COUNTRY (2019) 54
FIGURE 16 MEDICAL SIMULATION ANATOMICAL MODEL SEGMENT AND JAPAN ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020 54
4.3 MEDICAL SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 55
4.4 REGIONAL MIX: MEDICAL SIMULATION MARKET 56
FIGURE 18 NORTH AMERICA TO DOMINATE THE MEDICAL SIMULATION MARKET 
DURING THE FORECAST PERIOD 56
4.5 MEDICAL SIMULATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 56
FIGURE 19 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH 
DURING THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 20 MEDICAL SIMULATION MARKET: DRIVERS, RESTRAINTS, 
OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Limited access to patients during medical training 58
5.2.1.2 Rising technological advancements in medical education 58
5.2.1.3 Growing demand for minimally invasive treatments 59
5.2.1.4 Increasing focus on patient safety 59
5.2.1.5 Growing preference for virtual interaction due to the 
COVID-19 pandemic 59
 
5.2.2 RESTRAINTS 60
5.2.2.1 Limited availability of funds 60
5.2.2.2 Poorly designed medical simulators 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Shortage of healthcare personnel 61
5.2.3.2 Growing awareness for simulation training in emerging economies 61
5.2.4 MARKET CHALLENGES 62
5.2.4.1 High cost of simulators 62
5.2.4.2 Operational challenges 62
5.3 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 3 PORTER’S FIVE FORCES ANALYSIS 63
5.3.1 THREAT OF NEW ENTRANTS 63
5.3.2 THREAT OF SUBSTITUTES 64
5.3.3 BARGAINING POWER OF SUPPLIERS 64
5.3.4 BARGAINING POWER OF BUYERS 64
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.4 COVID-19 IMPACT ON THE MEDICAL SIMULATION MARKET 65
5.5 PRICING ANALYSIS 65
TABLE 4 PRICE RANGE FOR MEDICAL SIMULATION SOLUTIONS 66
5.6 TECHNOLOGY ANALYSIS 66
5.7 ECOSYSTEM ANALYSIS 67
5.7.1 MEDICAL SIMULATION MARKET: ECOSYSTEM ANALYSIS 67
5.8 PATENT ANALYSIS 67
5.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL SIMULATION 67
FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2021) 68
5.8.2 JURISDICTION AND TOP APPLICANT ANALYSIS 68
FIGURE 22 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL SIMULATION PATENTS (JANUARY 2011 TO JUNE 2021) 69
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL SIMULATION PATENTS (JANUARY 2011 TO JUNE 2021) 69
6 INDUSTRY INSIGHTS 70
6.1 INTRODUCTION 70
6.2 INDUSTRY TRENDS 70
6.2.1 USE OF VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR) 
IN MEDICAL SIMULATION 70
6.2.2 HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS 71
6.2.3 MULTIMODAL APPROACH IN THE DEVELOPMENT OF SIMULATORS 71
6.2.4 UTILISATION OF AI AND ML SOFTWARE IN SURGICAL PROCEDURES 71
6.2.5 GROWING USE OF HCIT/EMR 72
 
6.3 REGULATORY ANALYSIS 72
6.3.1 MEDICAL SIMULATION PRODUCTS 73
6.3.1.1 North America 73
6.3.1.1.1 US 73
TABLE 5 US: FDA CLASSIFICATIONS OF MEDICAL DEVICES 73
6.3.1.1.2 Canada 73
6.3.1.2 Europe 73
6.3.1.3 Asia Pacific 74
6.3.1.3.1 Japan 74
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 74
6.3.1.3.2 China 75
TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION 75
6.3.1.3.3 India 75
6.3.2 INTEROPERABILITY STANDARDS 76
TABLE 8 KEY STANDARDS FOR INTEROPERABILITY IN THE DIGITAL HEALTH SPECTRUM 76
TABLE 9 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN THE DIGITAL HEALTH SPECTRUM 78
7 GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE 79
7.1 INTRODUCTION 80
TABLE 10 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 80
TABLE 11 MEDICAL SIMULATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
7.2 MEDICAL SIMULATION ANATOMICAL MODELS 81
TABLE 12 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 82
TABLE 13 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 82
7.2.1 PATIENT SIMULATORS 83
TABLE 14 PATIENT SIMULATORS OFFERED BY KEY MARKET PLAYERS 84
TABLE 15 PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 85
TABLE 16 PATIENT SIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.2.1.1 High-fidelity Simulators 86
7.2.1.1.1 The growing adoption of high-fidelity simulators in the educational training of healthcare professionals supports the market growth 86
TABLE 17 HIGH-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS 87
TABLE 18 HIGH-FIDELITY PATIENT SIMULATOR MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 88
7.2.1.2 Medium-fidelity simulators 88
7.2.1.2.1 Medium-fidelity simulation is largely opted for over 
high-fidelity owing to its cost benefits 88
TABLE 19 MEDIUM-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS 89
TABLE 20 MEDIUM-FIDELITY PATIENT SIMULATOR MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 90
7.2.1.3 Low-fidelity simulators 90
7.2.1.3.1 Growing adoption of simulation training, budgetary constraints, and ease of use are the factors responsible for the growth of this segment 90
TABLE 21 LOW-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS 91
TABLE 22 LOW-FIDELITY PATIENT SIMULATOR MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 91
7.2.2 TASK TRAINERS 92
7.2.2.1 The inability of task trainers to imitate the emotional attributes of patients is expected to restrain the growth of this segment 92
TABLE 23 TASK TRAINERS OFFERED BY KEY MARKET PLAYERS 93
TABLE 24 TASK TRAINERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 94
7.2.3 INTERVENTIONAL/SURGICAL SIMULATORS 94
TABLE 25 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 95
TABLE 26 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 96
7.2.3.1 Laparoscopic surgical simulators 96
7.2.3.1.1 Increasing preference for minimally invasive surgeries to drive the growth of this segment 96
TABLE 27 LAPAROSCOPIC SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 97
TABLE 28 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 97
7.2.3.2 Gynecology simulators 98
7.2.3.2.1 Increasing incidence of diseases such as fibroids and polyps in women has propelled the growth of this segment 98
TABLE 29 GYNECOLOGY SIMULATORS OFFERED BY KEY MARKET PLAYERS 98
TABLE 30 GYNECOLOGY SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 99
7.2.3.3 Cardiovascular simulators 99
7.2.3.3.1 Increasing prevalence of obesity and diabetes to boost the demand for cardiovascular simulators 99
TABLE 31 CARDIOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS 100
TABLE 32 CARDIOVASCULAR SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 100
7.2.3.4 Orthopedic surgical simulators 101
7.2.3.4.1 Working through small portals with fragile instruments and being heavily time-consuming pose to be major challenges to the growth of this segment 101
TABLE 33 ORTHOPEDIC SIMULATORS OFFERED BY KEY MARKET PLAYERS 101
TABLE 34 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 102
7.2.3.5 Spine surgical simulators 102
7.2.3.5.1 Increasing spinal injuries to boost the growth of 
this segment 102
TABLE 35 SPINE SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 103
TABLE 36 SPINE SURGICAL SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 103
7.2.3.6 other surgical simulators 104
TABLE 37 OTHER SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 104
TABLE 38 OTHER SURGICAL SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 105
7.2.4 ENDOVASCULAR SIMULATORS 105
7.2.4.1 Endovascular simulators help in reducing mortality rates and offer shorter recovery periods for patients as compared to 
vascular procedures 105
TABLE 39 ENDOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS 106
TABLE 40 ENDOVASCULAR SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 107
7.2.5 ULTRASOUND SIMULATORS 107
7.2.5.1 Poor quality images resulting from low dynamics, spatial resolution, and signal to noise ratio restrict the growth of this segment 107
TABLE 41 ULTRASOUND SIMULATORS OFFERED BY KEY MARKET PLAYERS 108
TABLE 42 ULTRASOUND SIMULATORS MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 108
7.2.6 DENTAL SIMULATORS 109
7.2.6.1 The expanding dental tourism industry is driving the growing demand for dental simulators 109
TABLE 43 DENTAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 109
TABLE 44 DENTAL SIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
7.2.7 EYE SIMULATORS 110
7.2.7.1 The increasing incidence of eye disorders worldwide drive the growth of this segment 110
TABLE 45 EYE SIMULATORS OFFERED BY KEY MARKET PLAYERS 111
TABLE 46 EYE SIMULATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.2.8 WEB-BASED SIMULATION 112
7.2.8.1 Rising technological advancements are driving the adoption of 
web-based simulation in developing countries 112
TABLE 47 WEB-BASED SIMULATORS OFFERED BY KEY MARKET PLAYERS 112
TABLE 48 WEB-BASED SIMULATION MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 113
7.3 MEDICAL SIMULATION SOFTWARE 113
TABLE 49 MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 114
TABLE 50 MEDICAL SIMULATION SOFTWARE MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 114
7.3.1 PERFORMANCE RECORDING SOFTWARE 115
7.3.1.1 Compromised system integration and time constraints due to manual processes to restrain the growth of this segment 115
TABLE 51 PERFORMANCE RECORDING SOFTWARE OFFERED BY KEY MARKET PLAYERS 115
TABLE 52 PERFORMANCE RECORDING SOFTWARE MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 116
 
7.3.2 VIRTUAL TUTORS 116
7.3.2.1 Virtual reality helps reduce human errors in the medical sector 116
TABLE 53 VIRTUAL TUTORS OFFERED BY KEY MARKET PLAYERS 117
TABLE 54 VIRTUAL TUTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
7.4 SIMULATION TRAINING SERVICES 118
TABLE 55 MEDICAL SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 119
7.4.1 VENDOR-BASED TRAINING 119
7.4.1.1 High focus on patient safety for real-time clinical practices to propel the growth of the segment 119
TABLE 56 VENDOR-BASED TRAINING SERVICES OFFERED BY KEY MARKET PLAYERS 120
TABLE 57 VENDOR-BASED TRAINING SERVICES MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 121
7.4.2 EDUCATIONAL SOCIETIES 121
7.4.2.1 The growing need for proper training and authenticity of knowledge drives the growth of this segment 121
TABLE 58 EDUCATIONAL SOCIETIES SIMULATORS OFFERED BY KEY MARKET PLAYERS 122
TABLE 59 EDUCATIONAL SOCIETIES MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 122
7.4.3 CUSTOM CONSULTING SERVICES 123
7.4.3.1 The growing need to limit errors associated with traditional medical training systems to drive the growth of this segment 123
TABLE 60 CUSTOM CONSULTING SERVICES OFFERED BY KEY MARKET PLAYERS 123
TABLE 61 CUSTOM CONSULTING SERVICES MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 124
8 GLOBAL MEDICAL SIMULATION MARKET, BY END USER 125
8.1 INTRODUCTION 126
TABLE 62 MEDICAL SIMULATION MARKET, BY END USER, 2019–2026 (USD MILLION) 126
8.2 ACADEMIC INSTITUTES 126
8.2.1 THE GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS IS 
EXPECTED TO INCREASE THE USE OF MEDICAL SIMULATORS IN 
ACADEMIC INSTITUTIONS 126
TABLE 63 MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 127
8.3 HOSPITALS 128
8.3.1 THE SURGING NUMBER OF COVID-19 PATIENTS AND THE RISING 
FOCUS ON MINIMIZING MEDICAL ERRORS ARE KEY FACTORS DRIVING THE GROWTH OF THIS SEGMENT 128
TABLE 64 MEDICAL SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 
2019–2026 (USD MILLION) 129
8.4 MILITARY ORGANIZATIONS 129
8.4.1 INCREASING USE OF SIMULATORS TO EXPLORE NEW METHODS OF 
MEDICAL CARE DURING WARFARE CONDITIONS IS EXPECTED TO DRIVE 
THE GROWTH OF THIS SEGMENT 129
TABLE 65 MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, 
BY COUNTRY, 2019–2026 (USD MILLION) 130
8.5 OTHER END USERS 131
TABLE 66 MEDICAL SIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 131
9 GLOBAL MEDICAL SIMULATION MARKET, BY REGION 132
9.1 INTRODUCTION 133
FIGURE 24 MEDICAL SIMULATION MARKET: GEOGRAPHIC SNAPSHOT 133
TABLE 67 MEDICAL SIMULATION MARKET, BY REGION, 2019–2026 (USD MILLION) 134
9.2 NORTH AMERICA 134
FIGURE 25 NORTH AMERICA: MEDICAL SIMULATION MARKET SNAPSHOT (2020) 135
TABLE 68 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 135
TABLE 69 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 136
TABLE 70 NORTH AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 71 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 136
TABLE 72 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 73 NORTH AMERICA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 74 NORTH AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 75 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 138
9.2.1 US 138
9.2.1.1 The increasing demand for virtual tutors due to the COVID-19 pandemic and high healthcare spending to boost the market 
growth in the US 138
TABLE 76 US: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 139
TABLE 77 US: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 139
TABLE 78 US: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 79 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 140
TABLE 80 US: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 140
TABLE 81 US: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 140
TABLE 82 US: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 141
9.2.2 CANADA 141
9.2.2.1 Increasing funding and surgical capabilities to drive the market growth in Canada 141
TABLE 83 CANADA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 142
TABLE 84 CANADA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 85 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 143
TABLE 86 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 87 CANADA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 143
TABLE 88 CANADA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 89 CANADA: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 144
9.3 EUROPE 144
FIGURE 26 EUROPE: MEDICAL SIMULATION MARKET SNAPSHOT (2020) 146
TABLE 90 EUROPE: MEDICAL SIMULATION MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 147
TABLE 91 EUROPE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 147
TABLE 92 EUROPE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 93 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 148
TABLE 94 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 95 EUROPE: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 149
TABLE 96 EUROPE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 97 EUROPE: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 149
9.3.1 GERMANY 150
9.3.1.1 High healthcare spending to be the key driver for market 
growth in Germany 150
TABLE 98 GERMANY: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 150
TABLE 99 GERMANY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 100 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 151
TABLE 101 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 102 GERMANY: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 152
TABLE 103 GERMANY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 104 GERMANY: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 152
 
9.3.2 FRANCE 153
9.3.2.1 Growing focus towards the use of innovative methods of medical training to drive the market growth for simulators in France 153
TABLE 105 FRANCE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 153
TABLE 106 FRANCE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 107 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 154
TABLE 108 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 109 FRANCE: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 155
TABLE 110 FRANCE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 111 FRANCE: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 155
9.3.3 UK 156
9.3.3.1 Increasing healthcare expenditure and the rising number of healthcare simulation centers & hospitals in the UK to support the market growth 156
TABLE 112 UK: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) (USD MILLION) 157
TABLE 113 UK: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 157
TABLE 114 UK: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 115 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 158
TABLE 116 UK: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 158
TABLE 117 UK: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 158
TABLE 118 UK: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 159
9.3.4 ITALY 159
9.3.4.1 The growing burden of chronic conditions and the shortage of 
trained healthcare professions drive the demand for medical simulators in Italy 159
TABLE 119 ITALY: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 160
TABLE 120 ITALY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 121 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 122 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 161
TABLE 123 ITALY: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 161
TABLE 124 ITALY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 162
TABLE 125 ITALY: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 162
9.3.5 SPAIN 162
9.3.5.1 Increasing surgical procedures to boost the demand for 
simulators in Spain 162
TABLE 126 SPAIN: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 163
TABLE 127 SPAIN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 128 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 129 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 164
TABLE 130 SPAIN: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 164
TABLE 131 SPAIN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 165
TABLE 132 SPAIN: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 165
9.3.6 REST OF EUROPE (ROE) 165
TABLE 133 ROE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 166
TABLE 134 ROE: MANNEQUIN-BASED SIMULATION ANATOMICAL MODELS MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 135 ROE: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 136 ROE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 167
TABLE 137 ROE: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 167
TABLE 138 ROE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 168
TABLE 139 ROE: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 168
9.4 ASIA PACIFIC 168
FIGURE 27 ASIA PACIFIC: MEDICAL SIMULATION MARKET SNAPSHOT (2020) 169
TABLE 140 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY COUNTRY, 
2019–2026 (USD MILLION) 169
TABLE 141 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 170
TABLE 142 ASIA PACIFIC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 143 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 170
TABLE 144 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 145 ASIA PACIFIC: MEDICAL SIMULATION SOFTWARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 171
TABLE 146 ASIA PACIFIC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 147 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 172
9.4.1 JAPAN 172
9.4.1.1 Increasing demand for virtual tutors and technologically advanced simulators to drive the market growth in Japan 172
TABLE 148 JAPAN: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 173
TABLE 149 JAPAN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 150 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 151 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 174
TABLE 152 JAPAN: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 174
TABLE 153 JAPAN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 174
TABLE 154 JAPAN: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 175
9.4.2 CHINA 175
9.4.2.1 Growing demand for trained medical professionals to drive the market growth for medical simulators in China 175
TABLE 155 CHINA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 176
TABLE 156 CHINA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 157 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 158 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 177
TABLE 159 CHINA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 177
TABLE 160 CHINA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 177
TABLE 161 CHINA: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 178
9.4.3 INDIA 178
9.4.3.1 Growing awareness regarding patient safety due to healthcare negligence is a key factor supporting the market growth in India 178
TABLE 162 INDIA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 179
TABLE 163 INDIA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 164 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 165 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 180
TABLE 166 INDIA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 180
TABLE 167 INDIA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 181
TABLE 168 INDIA: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 181
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 181
TABLE 169 ROAPAC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 182
TABLE 170 ROAPAC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 171 ROAPAC: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 183
TABLE 172 ROAPAC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 173 ROAPAC: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 183
TABLE 174 ROAPAC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 175 ROAPAC: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 184
9.5 LATIN AMERICA 184
TABLE 176 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 185
TABLE 177 LATIN AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, 2019–2026 (USD MILLION) 185
TABLE 178 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 185
TABLE 179 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 180 LATIN AMERICA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 186
TABLE 181 LATIN AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, 2019–2026 (USD MILLION) 186
TABLE 182 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 187
9.5.1 BRAZIL 187
9.5.1.1 High incidence of chronic diseases to drive the demand for 
medical simulators in Brazil 187
TABLE 183 BRAZIL: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 188
TABLE 184 BRAZIL: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 185 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 188
TABLE 186 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 187 BRAZIL: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 189
TABLE 188 BRAZIL: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 189 BRAZIL: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 190
9.5.2 MEXICO 190
9.5.2.1 Disruptive technologies and private-public partnerships to boost the healthcare sector for medical simulation in Mexico 190
TABLE 190 MEXICO: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 190
TABLE 191 MEXICO: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 192 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 191
TABLE 193 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 194 MEXICO: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 192
TABLE 195 MEXICO: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 196 MEXICO: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 192
9.5.3 REST OF LATIN AMERICA 193
TABLE 197 ROLA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 
2019–2026 (USD MILLION) 193
TABLE 198 ROLA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 199 ROLA: PATIENT SIMULATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 200 ROLA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 194
TABLE 201 ROLA: MEDICAL SIMULATION SOFTWARE MARKET, BY TYPE, 
2019–2026 (USD MILLION) 195
TABLE 202 ROLA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 
2019–2026 (USD MILLION) 195
TABLE 203 ROLA: MEDICAL SIMULATION MARKET, BY END USER, 
2019–2026 (USD MILLION) 195
9.6 MIDDLE EAST & AFRICA 196
TABLE 204 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, 
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 196
TABLE 205 MIDDLE EAST & AFRICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 206 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 
2019–2026 (USD MILLION) 197
TABLE 207 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, 2019–2026 (USD MILLION) 197
TABLE 208 MIDDLE EAST & AFRICA: MEDICAL SIMULATION SOFTWARE MARKET, 
BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 209 MIDDLE EAST & AFRICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 210 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY END USER, 2019–2026 (USD MILLION) 198
 
10 COMPETITIVE LANDSCAPE 199
10.1 OVERVIEW 199
FIGURE 28 KEY PLAYER STRATEGIES 199
10.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 200
FIGURE 29 REVENUE ANALYSIS OF TOP PLAYERS IN THE MEDICAL SIMULATION MARKET 200
10.3 MARKET SHARE ANALYSIS 200
FIGURE 30 MEDICAL SIMULATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 201
FIGURE 31 SURGICAL SIMULATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 202
TABLE 211 INSIGHTS ON THE TOP AND OTHER PLAYERS IN THE SURGICAL 
SIMULATORS MARKET 203
10.4 COMPETITIVE LEADERSHIP MAPPING 205
10.4.1 STARS 205
10.4.2 EMERGING LEADERS 205
10.4.3 PERVASIVE PLAYERS 205
10.4.4 PARTICIPANTS 205
FIGURE 32 MEDICAL SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 206
10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 207
10.5.1 PROGRESSIVE COMPANIES 207
10.5.2 DYNAMIC COMPANIES 207
10.5.3 STARTING BLOCKS 207
10.5.4 RESPONSIVE COMPANIES 207
FIGURE 33 MEDICAL SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2020) 208
10.6 COMPETITIVE SCENARIO 209
10.6.1 PRODUCT LAUNCHES AND APPROVALS 209
TABLE 212 PRODUCT LAUNCHES & APPROVALS, 2018–2021 209
10.6.2 DEALS 211
TABLE 213 DEALS (2018–2021) 211
10.6.3 OTHER STRATEGIES 213
TABLE 214 OTHERS (2018-2021) 213
10.7 COMPETITIVE BENCHMARKING 214
FIGURE 34 FOOTPRINTS OF THE COMPANY IN THE MEDICAL SIMULATION MARKET 214
TABLE 215 COMPANY PRODUCT AND SERVICE OFFERING FOOTPRINT (25 COMPANIES) 215
TABLE 216 COMPANY REGION FOOTPRINT (25 COMPANIES) 216
11 COMPANY PROFILES 217
11.1 KEY PLAYERS 217
(Business Overview, Products/ Services Offered, Recent Developments, and MnM View)*
11.1.1 CAE INC. 217
FIGURE 35 CAE: COMPANY SNAPSHOT (2020) 218
11.1.2 3D SYSTEMS 222
FIGURE 36 3D SYSTEMS: COMPANY SNAPSHOT (2020) 222
11.1.3 LAERDAL MEDICAL 225
11.1.4 GAUMARD SCIENTIFIC CO. 231
11.1.5 KYOTO KAGAKU 241
11.1.6 LIMBS & THINGS 248
11.1.7 MENTICE AB 252
FIGURE 37 MENTICE AB: COMPANY SNAPSHOT (2020) 252
11.1.8 SIMULAB CORP. 255
11.1.9 SIMULAIDS 263
11.1.10 INTELLIGENT ULTRASOUND GROUP PLC 270
FIGURE 38 INTELLIGENT ULTRASOUND GROUP PLC: COMPANY SNAPSHOT (2020) 270
11.1.11 OPERATIVE EXPERIENCE INC. 273
11.1.12 SURGICAL SCIENCE SWEDEN AB 275
FIGURE 39 SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2020) 275
11.1.13 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC) 277
11.1.14 VIRTAMED AG 278
11.1.15 SYNBONE AG 280
11.1.16 INGMAR MEDICAL 282
11.1.17 MEDICAL-X 284
11.1.18 KAVO DENTAL GMBH 286
11.1.19 ALTAY SCIENTIFIC 287
11.1.20 SIMENDO B.V. 291
* Business Overview, Products/ Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 292
11.2.1 VRMAGIC HOLDING AG. 292
11.2.2 SYMGERY 292
11.2.3 HRV SIMULATION 293
11.2.4 SYNAPTIVE MEDICAL 293
11.2.5 INOVUS MEDICAL 294
12 APPENDIX 295
12.1 INSIGHTS OF INDUSTRY EXPERTS 295
12.2 DISCUSSION GUIDE 296
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 302
12.4 AVAILABLE CUSTOMIZATIONS 304
12.5 RELATED REPORTS 304
12.6 AUTHOR DETAILS 305

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

MarketsandMarkets社のその他分野での最新刊レポート

本レポートと同じKEY WORD（hospital）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21　10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.